HomeCSCI • TSE
add
COSCIENS Biopharma Inc
Previous close
$4.96
Day range
$4.82 - $4.91
Year range
$2.90 - $15.13
Market cap
15.35M CAD
Avg Volume
1.61K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 1.50M | -27.08% |
Operating expense | 4.06M | 400.07% |
Net income | -3.66M | -160.89% |
Net profit margin | -243.67 | -257.76% |
Earnings per share | — | — |
EBITDA | -3.29M | -225.84% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 13.76M | -53.43% |
Total assets | 31.14M | -2.05% |
Total liabilities | 21.00M | 11.56% |
Total equity | 10.14M | — |
Shares outstanding | 3.15M | — |
Price to book | 1.54 | — |
Return on assets | -27.31% | — |
Return on capital | -64.96% | — |
Cash Flow
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -3.66M | -160.89% |
Cash from operations | -1.88M | 21.70% |
Cash from investing | -615.00K | -9.04% |
Cash from financing | -200.00K | -177.78% |
Net change in cash | -2.64M | 16.93% |
Free cash flow | -1.75M | -170.68% |
About
Founded
1990
Headquarters
Website
Employees
40